دورية أكاديمية

Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials

التفاصيل البيبلوغرافية
العنوان: Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials
المؤلفون: Kauer, JosephAff1, Aff2, Freundt, Emma P., Schmitt, Anita, Weinhold, Niels, Mai, Elias K.Aff1, Aff3, Müller-Tidow, CarstenAff1, Aff2, Aff4, Goldschmidt, HartmutAff1, Aff3, Aff4, Raab, Marc S.Aff1, Aff4, Kriegsmann, KatharinaAff1, Aff5, Sauer, SandraAff1, IDs12885023115079_cor10
المصدر: BMC Cancer. 23(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:14712407
DOI:10.1186/s12885-023-11507-9